Tuberculosis News and Research

Latest Tuberculosis News and Research

C. difficile bacteria pose major health threat without proper infection prevention in hospitals, homes

Without proper infection prevention in hospitals, and now homes, the Clostridium difficile bacteria poses a major health threat, cautions a Case Western Reserve University infection control researcher.

17 Jun 2014

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).

12 Jun 2014

Otsuka Pharmaceutical begins tolvaptan Phase 3b study in patients with ADPKD

Otsuka Pharmaceutical Development & Commercialization, Inc., announced today that patient enrollment has begun for a new Phase 3b study of tolvaptan for adult patients with autosomal dominant polycystic kidney disease (ADPKD), the most common, life-threatening, inherited genetic kidney disorder.

11 Jun 2014

Anthrax, brucellosis and bovine TB fail to receive official recognition, say researchers

Decades of neglect have allowed infectious diseases to devastate the lives of thousands of people in the developing world, a study reveals.

9 Jun 2014

New TB blood test could eliminate unnecessary treatment

A new screening process for tuberculosis (TB) infections in Canadian prisons could mean that more than 50 per cent of those screened won't undergo unnecessary treatment due to false positives.

6 Jun 2014

Patients and families benefit from shorter TB treatment regimens

Shorter TB treatment regimens will reduce the out-of-pocket expenses incurred by both patients and their family members, who often act as the patients' guardians. In addition, shorter TB regimens may allow an earlier return to productive activities for patients and their families.

5 Jun 2014

UK makes £5.64M investment in most advanced crystallography technology

The UK's structural biology community will have access to the most advanced crystallography technology in the world thanks to a - £5.64M investment from UK research funders.

3 Jun 2014

Growing resistance to antibiotics demands a coordinated global response, say experts

Growing resistance to antibiotics and other drugs demands a coordinated global response on the same scale as efforts to address climate change, experts say.

23 May 2014

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis

AbbVie announced today that the U.S. Food and Drug Administration has granted HUMIRA orphan drug designation for the treatment of non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis, a group of rare but serious inflammatory diseases of the eye.

21 May 2014

Disease-causing bacteria can linger in airplane cabins for days, says study

Disease-causing bacteria can linger on surfaces commonly found in airplane cabins for days, even up to a week, according to research presented at the annual meeting of the American Society for Microbiology.

21 May 2014

Chronic bystander viral impairs development of memory T cells

Studies of vaccine programs in the developing world have revealed that individuals with chronic infections such as malaria and hepatitis tend to be less likely to develop the fullest possible immunity benefits from vaccines for unrelated illnesses.

16 May 2014

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Data from a retrospective pooled analysis of eight phase III trials (two 18-week and six 24-week) of linagliptin 5 mg once-daily, showed reductions from baseline A1c at 18 (eight trials) and 24 (six trials) weeks compared to placebo in African-American adults with type 2 diabetes (T2D),

16 May 2014

WHO's annual statistics report shows global life expectancy continues to increase

People everywhere are living longer, according to the "World Health Statistics 2014" published today by WHO. Based on global averages, a girl who was born in 2012 can expect to live to around 73 years, and a boy to the age of 68.

15 May 2014

Findings from 1918 Flu Pandemic research could help improve current health policies

The 1918 Flu Pandemic infected over 500 million people, killing at least 50 million. Now, a researcher at the University of Missouri has analyzed the pandemic in two remote regions of North America, finding that despite their geographical divide, both regions had environmental, nutritional and economic factors that influenced morbidity during the pandemic.

15 May 2014

Researchers find TB infection in lungs may decrease diversity of gut bacteria in mice

Johns Hopkins researchers have found evidence in mice that a tuberculosis (TB) infection in the lungs triggers immune system signaling to the gut that temporarily decreases the diversity of bacteria in that part of the digestive tract.

14 May 2014

Highlights: Mass. death rate drops after universal coverage; Calif. immigrant licensing; Calif. offenders mental health treatment

The mortality rate in Massachusetts declined substantially in the four years after the state enacted a law in 2006 mandating universal health care coverage, providing the model for the Affordable Care Act.

13 May 2014

Tuberculosis News and Research

Latest Tuberculosis News and Research

C. difficile bacteria pose major health threat without proper infection prevention in hospitals, homes

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Otsuka Pharmaceutical begins tolvaptan Phase 3b study in patients with ADPKD

Anthrax, brucellosis and bovine TB fail to receive official recognition, say researchers

New TB blood test could eliminate unnecessary treatment

Patients and families benefit from shorter TB treatment regimens

UK makes £5.64M investment in most advanced crystallography technology

Growing resistance to antibiotics demands a coordinated global response, say experts

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis

Disease-causing bacteria can linger in airplane cabins for days, says study

Chronic bystander viral impairs development of memory T cells

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

WHO's annual statistics report shows global life expectancy continues to increase

Findings from 1918 Flu Pandemic research could help improve current health policies

Researchers find TB infection in lungs may decrease diversity of gut bacteria in mice

Highlights: Mass. death rate drops after universal coverage; Calif. immigrant licensing; Calif. offenders mental health treatment

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Inflammatory pneumococcal response differs by age

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

New hope for improved diagnosis of children with TB

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Tuberculosis News and Research

Latest Tuberculosis News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in